Press Release: Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dow Jones11/02 04:05

Akebia Therapeutics to Report Third Quarter 2024 Financial Results and Discuss Recent Business Highlights

PR Newswire11/01 20:00

Akebia Therapeutics, Inc.'s (NASDAQ:AKBA) Shares Bounce 29% But Its Business Still Trails The Industry

Simply Wall St10/30 19:09

Market Sentiment Around Loss-Making Akebia Therapeutics, Inc. (NASDAQ:AKBA)

Simply Wall St10/23 19:48

Akebia Stock Climbs 8% on Dialysis Provider Supply Agreement

Seeking Alpha10/22 22:54

Akebia Therapeutics Signs A Multi-Year Commercial Contract With One Of The Nation's Leading Providers Of Kidney Care Services, Expanding Access To Vafseo For Patients On Dialysis; The Contract Enables Physicians To Prescribe Vafseo To Patients On...

Benzinga10/22 20:10